Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma.

British journal of haematology - 1 Jul 2017

Dutta Ankit K, Hewett Duncan R, Fink J Lynn, Grady John P, Zannettino Andrew C W

Abstract excerpt

Multiple Myeloma (MM) is a haematological malignancy characterised by the clonal expansion of plasma cells (PCs) within the bone marrow. Despite advances in therapy, MM remains a largely incurable disease with a median survival of 6 years. In almost all cases, the development of MM is preceded by the benign PC condition Monoclonal Gammopathy of Undetermined Significance (MGUS). Recent studies show that the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enzyme Inhibitors

Share to Epigenesis, Genetic

Share to Forecasting

Share to Genomics

Share to Immunologic Factors

Share to Multiple Myeloma

Source

Identifiers

PMID: 28466550
DOI: 10.1111/bjh.14649

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma.PMID 28466550Read ↗

Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic ImplicationsSemantic proximity Read ↗

Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms.Semantic proximity Read ↗

Subclonal evolution in disease progression from MGUS/SMM to multiple myeloma is characterised by clonal stabilitySemantic proximity Read ↗

Evolutionary biology of high-risk multiple myeloma.Semantic proximity Read ↗

Reconstructing the evolutionary history of multiple myeloma.Semantic proximity Read ↗

A Journey Through Myeloma Evolution: From the Normal Plasma Cell to Disease ComplexitySemantic proximity Read ↗

Evolution of multiple myeloma from a genomic perspective.Semantic proximity Read ↗

A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics.Semantic proximity Read ↗

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.Semantic proximity Read ↗

Molecular basis of clonal evolution in multiple myeloma.Semantic proximity Read ↗

Genomic complexity of multiple myeloma and its clinical implications.Semantic proximity Read ↗

Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple MyelomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.